Shrinidhi Nathany on Simulating Cells and Why It is a Game Changer
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn:
“Thought provoking read
What if we could simulate the cell?
For years, the idea of a virtual cell sounded unrealistic. Cells are complex, dynamic, and shaped by countless molecular interactions. Today, that view is changing.
With advances in single cell biology, spatial omics, perturbation data, and AI, scientists are beginning to build models that can predict how cells respond to genes, drugs, and environmental signals. These are not perfect replicas, but practical, predictive systems.
Virtual cells could transform drug discovery and precision medicine by allowing millions of experiments to be run computationally, guiding lab work, improving patient selection, and helping match the right therapy to the right patient.
The challenges are real, especially data scale and quality. But the direction is clear.
Making the cell predictable would redefine how we study disease and design treatments. The virtual cell is no longer science fiction. It is becoming a new tool for biology.”
Title: Inside the Virtual Cell: New Depths for Precision Medicine
Authors: Clara Rodriguez Fernandez
Read full article here.
Stay informed with Hemostasis Today.
-
Mar 17, 2026, 15:10Peter Zdziarski: Standing Together for Ultra Rare Bleeding Disorders Awareness Day
-
Mar 17, 2026, 14:58Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden – Closure or Lifelong Anticoagulation?
-
Mar 17, 2026, 14:56Mahesan Subramaniam: A Visual Guide to Heart Valve Disease
-
Mar 17, 2026, 14:55Daniel Victor Ortigoza: Apixaban Shows Lower Bleeding Risk than Rivaroxaban in Acute VTE
-
Mar 17, 2026, 14:52Kanishk Kumar: ATTR Amyloidosis Therapeutics Market Poised for a Pipeline Revolution
-
Mar 17, 2026, 14:39Giordano Botta: VA and Allelica Partner on Clinical Study of PRS and PGx in Cardiovascular Prevention
-
Mar 17, 2026, 14:34Rishi Wadhera: Financial Burden Among Working-Age Adults With Cardiovascular Disease
-
Mar 17, 2026, 14:32Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients
-
Mar 17, 2026, 14:31Applications Now Open for ISTH Fundamental Research Career Award